Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study

M. O’Neil, Patrick; R. Smith, Steven; J. Weissman, Neil; C. Fidler, Meredith; Sanchez, Matilde; Zhang, Jinkun; Raether, Brian; M. Anderson, Christen; Shanahan, William

doi:10.1038/oby.2012.66

Public

Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study

Published in Obesity • Mar 16, 2012

Authors:

Patrick M. O’Neil

Steven R. Smith

Neil J. Weissman

Abstract

The BLOOM-DM (Behavioral Modification and Lorcaserin for Obesity and Overweight Management in Diabetes Mellitus) study evaluated efficacy and safety of lorcaserin for weight loss in patients with type 2 diabetes. Secondary objectives included evaluations of glycemic control, lipids, blood pressure, ...

Subject

Medicine

Placebo

Randomized controlled trial

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!